GHB16L2
GHB-CS08
Phase 2 mab completed
Quick answer
GHB16L2 for Influenza, Human is a Phase 2 program (mab) at Atea Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Atea Pharmaceuticals
- Indication
- Influenza, Human
- Phase
- Phase 2
- Modality
- mab
- Status
- completed